
Wise's Primat bolts on IEB
Italian industrial business Primat, backed by Wise, has acquired electrolytic treatments company Industria Elettrochimica Bergamasca (IEB) for an undisclosed amount.
Following the merger, the group will be able to provide the entire cycle of external zinc-based treatments for industrial parts and aims to post an aggregate turnover of €40m in 2017, the company said in a statement.
With its news acquisition, Primat aims to expand further its business across Europe.
Italian private equity fund manager Wise acquired a stake in Primat in 2014 via its Wisequity III vehicle. The current deal marks the second bolt-on acquisition for the business during its private equity ownership period, having acquired competitor Zincatura Reggiana following its MBO.
In 2016, Primat generated €30m of revenues, according to a statement.
Company
Established in 1957 and headquartered in Medalogo, near Bergamo, IEB manufactures zinc and zinc-nickel electrolytic treatments and focuses mainly on the automotive, electromechanical and household appliance sectors.
People
Wise – Fabrizio Medea (partner); Luigi Vagnozzi (director).
Primat – Camillo Rumi (CEO).
Advisers
Equity – Simmons&Simmons (legal); Spada Partners (tax).
Vendor – UBI Banca (M&A); K&L Gates (legal); Consult Studio (tax).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater